Roberta Blaj

Tanner Pharma Group is a global specialty services provider partnering with biotech, pharmaceutical companies, CROs, and generic manufacturers to accelerate clinical development, expand global access, and ensure continuity of supply across the full product lifecycle. Operating in over 150 countries, Tanner delivers three core service pillars: Clinical Trial Services – End-to-end, risk-managed clinical supply solutions supporting early- and late-phase trials, including comparator sourcing, ancillary supply, packaging and labeling, and global distribution. Global Access – Named Patient programs enabling treatment access prior to commercialization in countries where products are not yet approved, while maintaining full regulatory compliance and sponsor control. Managed Access – Scalable programs including Early Access, compassionate use, post-trial supply, and global donation initiatives, supported by centralized governance, regulatory coordination, and demand forecasting. Tanner also supports injectable generic manufacturers with agile, compliant solutions to address shortages, manufacturing disruptions, and demand fluctuations—ensuring continuity of care and protecting market position. All services are delivered through a fully integrated global infrastructure, including supply chain logistics, GMP/GDP operations, regulatory affairs, pharmacovigilance, and quality assurance—ensuring consistent, scalable, and high-quality execution worldwide. Tanner Pharma Group acts as a flexible, execution-driven partner, enabling sustainable global growth while reducing operational complexity.